Form 8-K - Current report:
SEC Accession No. 0001558370-24-015526
Filing Date
2024-11-13
Accepted
2024-11-13 16:10:56
Documents
17
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20241113x8k.htm   iXBRL 8-K 37332
2 EX-99.1 armp-20241113xex99d1.htm EX-99.1 207142
3 GRAPHIC armp-20241113xex99d1001.jpg GRAPHIC 2307
  Complete submission text file 0001558370-24-015526.txt   415798

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20241113.xsd EX-101.SCH 4399
5 EX-101.DEF armp-20241113_def.xml EX-101.DEF 2863
6 EX-101.LAB armp-20241113_lab.xml EX-101.LAB 11598
7 EX-101.PRE armp-20241113_pre.xml EX-101.PRE 11338
19 EXTRACTED XBRL INSTANCE DOCUMENT armp-20241113x8k_htm.xml XML 4702
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 241454287
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)